P
Protagonist Therapeutics D
D
PTGX
97.390
USD
-5.49
(-5.34%)
مغلق
حجم التداول
39,938
الربح لكل سهم
5
العائد الربحي
-
P/E
-54
حجم السوق
6,263,284,616
المقالات
العنوان: Protagonist Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.
